Document is current
Any future updates will be listed below
-
Authors
Navas, Angelo https://orcid.org/0000-0002-9036-4486
Noone, Joshua
Laney, Nathan
Sheth, Sunny
Tan, Xi
Liang, Yuanjie
Munoz, Paloma
Swift, Caroline
-
Funding
Funding for this research was provided by:
Novo Nordisk Inc.
- License Information
-
More Information
Article History
Received: 26 February 2026
Accepted: 24 April 2026
First Online: 9 May 2026
Declarations
:
: Angelo Navas received a UNC predoctoral fellowship funded by Novo Nordisk Inc. Joshua Noone, Nathan Laney, Xi Tan, Yuanjie Liang, Paloma Munoz, and Caroline Swift are employees of Novo Nordisk Inc. Sunny Sheth was an employee of Novo Nordisk Inc. at the time of this study.
: The SUSTAIN-6 trial was conducted in accordance with the principles of the Declaration of Helsinki and Good Clinical Practice guidelines. Approval was obtained from institutional review boards or independent ethics committees at each participating site, and all participants provided written informed consent [ ]. This post hoc analysis was determined to be exempt from institutional review board review by WCG IRB under 45 CFR 46.104(d)(4).
